Literature DB >> 25732997

Two Novel Mutations in the SLC25A4 Gene in a Patient with Mitochondrial Myopathy.

I M L W Körver-Keularts1, M de Visser, H D Bakker, R J A Wanders, F Vansenne, H R Scholte, L Dorland, G A F Nicolaes, L M J Spaapen, H J M Smeets, A T M Hendrickx, B J C van den Bosch.   

Abstract

In a 28-year-old male with a mild mitochondrial myopathy manifesting as exercise intolerance and early signs of cardiomyopathy without muscle weakness or ophthalmoplegia, we identified two novel mutations in the SLC25A4 gene: c.707G>C in exon 3 (p.(R236P)) and c.116_137del in exon 2 (p.(Q39Lfs*14)). Serum lactate levels at rest were elevated (12.7 mM). Both the patient's father and brother were heterozygous carriers of the c.707G>C mutation and were asymptomatic. The second mutation causes a 22 bp deletion leading to a frame shift likely giving rise to a premature stop codon and nonsense-mediated decay (NMD). The segregation of the mutations could not be tested directly as the mother had died before. However, indirect evidence from NMD experiments showed that the two mutations were situated on two different alleles in the patient. This case is unique compared to other previously reported patients with either progressive external ophthalmoplegia (PEO) or clear hypertrophic cardiomyopathy with exercise intolerance and/or muscle weakness carrying recessive mutations leading to a complete absence of the SLC25A4 protein. Most likely in our patient, although severely reduced, SLC25A4 is still partially present and functional.

Entities:  

Year:  2015        PMID: 25732997      PMCID: PMC4486268          DOI: 10.1007/8904_2015_409

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  25 in total

1.  Structure of mitochondrial ADP/ATP carrier in complex with carboxyatractyloside.

Authors:  Eva Pebay-Peyroula; Cécile Dahout-Gonzalez; Richard Kahn; Véronique Trézéguet; Guy J-M Lauquin; Gérard Brandolin
Journal:  Nature       Date:  2003-11-06       Impact factor: 49.962

2.  A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator.

Authors:  B H Graham; K G Waymire; B Cottrell; I A Trounce; G R MacGregor; D C Wallace
Journal:  Nat Genet       Date:  1997-07       Impact factor: 38.330

3.  A human muscle adenine nucleotide translocator gene has four exons, is located on chromosome 4, and is differentially expressed.

Authors:  K Li; C K Warner; J A Hodge; S Minoshima; J Kudoh; R Fukuyama; M Maekawa; Y Shimizu; N Shimizu; D C Wallace
Journal:  J Biol Chem       Date:  1989-08-25       Impact factor: 5.157

4.  Complete loss of expression of the ANT1 gene causing cardiomyopathy and myopathy.

Authors:  Andoni Echaniz-Laguna; Maïté Chassagne; Jennifer Ceresuela; Isabelle Rouvet; Sylvie Padet; Cécile Acquaviva; Serge Nataf; Stéphane Vinzio; Dominique Bozon; Bénédicte Mousson de Camaret
Journal:  J Med Genet       Date:  2011-12-20       Impact factor: 6.318

5.  Adenine nucleotide translocator deficiency in muscle: potential therapeutic value of vitamin E.

Authors:  H D Bakker; H R Scholte; C Van den Bogert; J A Jeneson; W Ruitenbeek; R J Wanders; N G Abeling; A H van Gennip
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

6.  Deficiency of the adenine nucleotide translocator in muscle of a patient with myopathy and lactic acidosis: a new mitochondrial defect.

Authors:  H D Bakker; H R Scholte; C Van den Bogert; W Ruitenbeek; J A Jeneson; R J Wanders; N G Abeling; B Dorland; R C Sengers; A H Van Gennip
Journal:  Pediatr Res       Date:  1993-04       Impact factor: 3.756

7.  Membrane protein oligomeric structure and transport function.

Authors:  M Klingenberg
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

8.  DNA sequences of two expressed nuclear genes for human mitochondrial ADP/ATP translocase.

Authors:  A L Cozens; M J Runswick; J E Walker
Journal:  J Mol Biol       Date:  1989-03-20       Impact factor: 5.469

9.  Differential expression of adenine nucleotide translocator isoforms in mammalian tissues and during muscle cell differentiation.

Authors:  G Stepien; A Torroni; A B Chung; J A Hodge; D C Wallace
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

Review 10.  Molecular aspects of the adenine nucleotide carrier from mitochondria.

Authors:  M Klingenberg
Journal:  Arch Biochem Biophys       Date:  1989-04       Impact factor: 4.013

View more
  13 in total

1.  Low expression of ANT1 confers oncogenic properties to rhabdomyosarcoma tumor cells by modulating metabolism and death pathways.

Authors:  J Vial; P Huchedé; S Fagault; F Basset; M Rossi; J Geoffray; H Soldati; J Bisaccia; M H Elsensohn; M Creveaux; D Neves; J Y Blay; F Fauvelle; F Bouquet; N Streichenberger; N Corradini; C Bergeron; D Maucort-Boulch; P Castets; M Carré; K Weber; M Castets
Journal:  Cell Death Discov       Date:  2020-07-24

Review 2.  Consequences of inner mitochondrial membrane protein misfolding.

Authors:  Liam P Coyne; Xin Jie Chen
Journal:  Mitochondrion       Date:  2019-06-10       Impact factor: 4.160

Review 3.  Phenotypic spectrum of SLC25A4 mutations.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Biomed Rep       Date:  2018-06-20

4.  A Yeast-Based Screening Unravels Potential Therapeutic Molecules for Mitochondrial Diseases Associated with Dominant ANT1 Mutations.

Authors:  Giulia di Punzio; Maria Antonietta Di Noia; Agnès Delahodde; Carole Sellem; Claudia Donnini; Luigi Palmieri; Tiziana Lodi; Cristina Dallabona
Journal:  Int J Mol Sci       Date:  2021-04-24       Impact factor: 5.923

Review 5.  MtDNA-maintenance defects: syndromes and genes.

Authors:  Carlo Viscomi; Massimo Zeviani
Journal:  J Inherit Metab Dis       Date:  2017-03-21       Impact factor: 4.982

6.  Low expression of ANT1 confers oncogenic properties to rhabdomyosarcoma tumor cells by modulating metabolism and death pathways.

Authors:  J Vial; P Huchedé; S Fagault; F Basset; M Rossi; J Geoffray; H Soldati; J Bisaccia; M H Elsensohn; M Creveaux; D Neves; J Y Blay; F Fauvelle; F Bouquet; N Streichenberger; N Corradini; C Bergeron; D Maucort-Boulch; P Castets; M Carré; K Weber; M Castets
Journal:  Cell Death Discov       Date:  2020-07-24

Review 7.  Diseases Caused by Mutations in Mitochondrial Carrier Genes SLC25: A Review.

Authors:  Ferdinando Palmieri; Pasquale Scarcia; Magnus Monné
Journal:  Biomolecules       Date:  2020-04-23

8.  The mitochondrial carrier SFXN1 is critical for complex III integrity and cellular metabolism.

Authors:  Michelle Grace Acoba; Ebru S Selen Alpergin; Santosh Renuse; Lucía Fernández-Del-Río; Ya-Wen Lu; Oleh Khalimonchuk; Catherine F Clarke; Akhilesh Pandey; Michael J Wolfgang; Steven M Claypool
Journal:  Cell Rep       Date:  2021-03-16       Impact factor: 9.423

9.  Recurrent De Novo Dominant Mutations in SLC25A4 Cause Severe Early-Onset Mitochondrial Disease and Loss of Mitochondrial DNA Copy Number.

Authors:  Kyle Thompson; Homa Majd; Cristina Dallabona; Karit Reinson; Martin S King; Charlotte L Alston; Langping He; Tiziana Lodi; Simon A Jones; Aviva Fattal-Valevski; Nitay D Fraenkel; Ann Saada; Alon Haham; Pirjo Isohanni; Roshni Vara; Inês A Barbosa; Michael A Simpson; Charu Deshpande; Sanna Puusepp; Penelope E Bonnen; Richard J Rodenburg; Anu Suomalainen; Katrin Õunap; Orly Elpeleg; Ileana Ferrero; Robert McFarland; Edmund R S Kunji; Robert W Taylor
Journal:  Am J Hum Genet       Date:  2016-09-29       Impact factor: 11.025

Review 10.  Saccharomyces cerevisiae as a Tool for Studying Mutations in Nuclear Genes Involved in Diseases Caused by Mitochondrial DNA Instability.

Authors:  Alexandru Ionut Gilea; Camilla Ceccatelli Berti; Martina Magistrati; Giulia di Punzio; Paola Goffrini; Enrico Baruffini; Cristina Dallabona
Journal:  Genes (Basel)       Date:  2021-11-24       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.